Cancer combo trial halted early after just 3 patients
NCT ID NCT06509906
First seen Jan 10, 2026 · Last updated May 15, 2026 · Updated 24 times
Summary
This early-stage study tested a new drug called M9466 combined with chemotherapy for people with advanced solid tumors, including colorectal cancer. The main goal was to check safety and find the right dose. The study was stopped early and only enrolled 3 participants, so no strong conclusions can be drawn.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Research SA
Elizabeth Vale, Australia
-
Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center
Pennington, New Jersey, 08534, United States
-
NEXT Barcelona - NEXT Barcelona
Barcelona, Spain
-
NEXT Madrid - Hospital Universitario Quironsalud Madrid
Pozuelo de Alarcón, Spain
-
National Cancer Center Hospital
Chūōku, Japan
-
Peter MacCallum Cancer Centre - Use the one with Account 2 VCCC
Parkville, Australia
-
Samsung Medical Center
Seoul, South Korea
-
Sarah Cannon Research Institute at Health One
Denver, Colorado, 80218, United States
-
Seoul National University Hospital
Seoul, South Korea
-
St George Private Hospital
Kogarah, Australia
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030-4009, United States
-
Vanderbilt University - 150912667
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.